The R.E.N.A.L score's relevance in determining perioperative and oncological outcomes: a Middle-Eastern tertiary care center experience
- PMID: 35935911
- PMCID: PMC9354629
- DOI: 10.1080/2090598X.2022.2064041
The R.E.N.A.L score's relevance in determining perioperative and oncological outcomes: a Middle-Eastern tertiary care center experience
Abstract
Objective: The aim of this study is to evaluate the significance of the R.E.N.A.L nephrometry scoring system in predicting perioperative and oncological outcomes and determining the surgical approach of choice for kidney tumors.Patients and Methods: Our study retrospectively reviewed outcomes from the year 2002 to 2017. Mann-Whitney U test was used to compare continuous variables and chi-square test was used to compare categorical variables. Kaplan-Meier estimates and multivariable cox proportional hazard regression were performed to determine an association between the different R.E.N.A.L categories and disease recurrence or mortality.
Results: A total of 325 patients underwent kidney surgery The most common R.E.N.A.L score category in our cohort study was intermediate (41.2%), followed by low, (33.2%) and high (25.5%). Patients with a high R.E.N.A.L score had worse perioperative outcomes compared to those with a low R.E.N.A.L score. High R.E.N.A.L score patients were 3 times more likely to receive blood transfusions compared to those with a low R.E.N.A.L score (19.4% vs 6.3%, p = 0.018), and a statistically significant longer hospital length of stay was also observed between the two groups (median 4.5 vs 4 days, p = 0.0419). In addition, the only predictor of disease recurrence or mortality was a high R.E.N.A.L score (Hazard Ratio (HR) 3.65, 95% Confidence Interval (CI) 1.05-12.7, p = 0.041).
Conclusion: Our study sheds light on the use of R.E.N.A.L nephrometry score in predicting perioperative, postoperative, and oncological outcomes. Such findings may play a role in optimizing surgical approaches and pre-operative patient counseling.
Keywords: Kidney cancer; RENAL score; kidney tumor; outcomes; renal cell cancer.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
R.E.N.A.L. Nephrometry Score Predicts Non-neoplastic Parenchymal Volume Removed During Robotic Partial Nephrectomy.J Endourol. 2016 Oct;30(10):1099-1104. doi: 10.1089/end.2016.0337. J Endourol. 2016. PMID: 27604690
-
Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score.BJU Int. 2014 Nov;114(5):708-18. doi: 10.1111/bju.12580. Epub 2014 Oct 3. BJU Int. 2014. PMID: 24274650
-
PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database.BJU Int. 2017 Mar;119(3):456-463. doi: 10.1111/bju.13628. Epub 2016 Sep 11. BJU Int. 2017. PMID: 27528265
-
Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis.Eur Urol Focus. 2020 May 15;6(3):490-504. doi: 10.1016/j.euf.2019.11.004. Epub 2019 Nov 24. Eur Urol Focus. 2020. PMID: 31776071
-
Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study.Health Technol Assess. 2022 Jan;26(6):1-166. doi: 10.3310/ABUT7744. Health Technol Assess. 2022. PMID: 35094747
Cited by
-
Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material.J Cancer Res Clin Oncol. 2023 Nov;149(17):15855-15865. doi: 10.1007/s00432-023-05353-2. Epub 2023 Sep 6. J Cancer Res Clin Oncol. 2023. PMID: 37672076 Free PMC article.
References
-
- Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009. Oct;182(4):1271–1279. - PubMed
-
- Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 Update. Eur Urol. 2019. May;75(5):799–810. - PubMed
-
- Patard JJ, Shvarts O, Lam JS, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004. Jun;1716 Pt 1:2181–2185. quiz 2435. - PubMed
-
- Patel MN, Krane LS, Bhandari A, et al. Robotic Partial Nephrectomy for Renal Tumors Larger Than 4 cm. Eur Urol. 2010;57(2):310–316. - PubMed
LinkOut - more resources
Full Text Sources
Medical